Using the TCGA BLCA cohort (n = 408), we observed that patients bearing high MED10 expression with or without high MDSC levels exhibited worse survival rates relative to those with concurrent low MED10 and low MDSC levels (R2 = 0.13, p = 3.67e-07) (Figure 2H). Here, MED10 is linked to bladder transitional cell carcinoma.